Loading clinical trials...

Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine | Clinical Trials | Clareo Health

UNKNOWNNA

Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine

NCT01914445•Hillel Yaffe Medical Center

Summary

The purpose of this study is to examine whether oral administration of Indigo Carmine together with Polyethylene Glycol (PEG), the usual colon preparatory solution, can be used instead of staining during the examination itself.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients suffering from Inflammatory Bowel Disease
•Patients under surveillance for Disease-Associated Lesions and Masses (DALM)

Exclusion Criteria

•All others

Locations (1)

Hillel Yaffe Medical Center

Hadera, Israel

Key Dates

Start Date

August 1, 2013

Primary Completion Date

December 1, 2013

Completion Date

December 1, 2013

Last Updated

August 2, 2013

Enrollment

ESTIMATED participants

Conditions

Inflammatory Bowel Diseases

Interventions

Indigo Carmine

DRUG

Contacts

Vitaly Verzhbitsky, MD

CONTACT

972-505703554 vitalyv@hy.health.gov.il

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883

Inflammatory Bowel DiseasesCrohn's Disease

View study

RECRUITING

Institutional Registry of Rare Diseases

NCT06573723

Rare DiseasesAmyloidosis+24 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2013Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine

Inclusion Criteria

Exclusion Criteria

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Institutional Registry of Rare Diseases

Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Clinnova-IBD, a Prospective Cohort of Patients With Inflammatory Bowel Disease (IBD)

Therapeutic Endpoint in Pediatric IBD Conditions